Kimmeridge Issues Letter Calling Out SilverBow's Misstatements and Misrepresentation of Kimmeridge's Intent
Get Alerts SBOW Hot Sheet
Join SI Premium – FREE
SilverBow has sought to distract from the issues that plague the Company and that require new, qualified, independent board members: namely chronic underperformance, negative TSR, poor capital allocation and worst-in-class governance
This proxy contest was initiated prior to discussions of a KTG combination, and is solely focused on fixing the Company and creating shareholder value
Urges shareholders to vote "FOR" all three of Kimmeridge's highly qualified, independent nominees to SilverBow's nine-person staggered board on the GOLD proxy card
Fellow Shareholders,
Throughout our engagement with SilverBow over the past two years, Kimmeridge's goal has been clear and consistent: to position the Company for a sustainable future and drive value creation for ALL shareholders.
Unfortunately, rather than engage constructively, the SilverBow Board of Directors ("Board") has continued its long-standing pattern of prioritizing self-preservation over shareholder returns. In recent weeks, the incumbent Board has repeatedly misled shareholders about Kimmeridge's actions and intent.
False Claim 1: SilverBow asserts that Kimmeridge nominated directors to the Board solely to force a combination with Kimmeridge Texas Gas ("KTG" and the "KTG Combination").
The Facts: Kimmeridge privately informed the Company on
On February 26, 2024, SilverBow CEO Sean Woolverton called Kimmeridge founder
On
Make no mistake – the Board invited an offer from Kimmeridge with no intent of engagement or negotiation on the KTG Combination, knowing that it was facing a proxy contest, and then misstated this timeline to proxy advisors and shareholders, to misrepresent Kimmeridge's intent.
False Claim 2: SilverBow stated that in
The Facts: Contrary to what SilverBow claims, in emails sent on
Additionally, Kimmeridge asked the Company to consider removing the poison pill and offered to commit itself to a standstill as a show of good faith. Kimmeridge never implied in its communications that the proxy contest would be used to take control of the Company.
False Claim 3: SilverBow stated that Kimmeridge threatened to take control of the Company through a tender offer on
The Facts: This is patently false: Kimmeridge never made such a statement or even raised the prospect of acquiring the Company through a tender offer – on
False Claim 4: The Board adopted a short duration poison pill to prevent Kimmeridge from acquiring the Company without paying any control premium.
The Facts: In 2022, Kimmeridge thought it was negotiating a zero-premium merger between SilverBow and KTG. Prior to any meaningful engagement, the Board adopted what Kimmeridge understands to be the industry's only poison pill. Kimmeridge has not acquired any shares in over 670 days, even though its ownership sits well below the poison pill's 15% trigger.
SilverBow's poison pill has never been about protecting shareholders' interests from a no-premium hostile takeover. It is about protecting management and the Board. SilverBow will never submit the poison pill to a shareholder vote because the Board knows shareholders won't support it. The Board unilaterally extended its long-term poison pill and has now conveniently scheduled the poison pill to expire the day after the Annual Meeting, but it will most likely be unilaterally extended – once again – by the Board.
Kimmeridge's nominees are more qualified, more knowledgeable and more independent than SilverBow's incumbent slate. After 7 years of negative total shareholder returns, the lowest EV/EBITDA multiple of its peer group and a fortress of terrible governance, shareholders deserve robust, independent oversight in the boardroom.
Kimmeridge's nominees are E&P industry leaders who can create sustained value for all SilverBow shareholders against the backdrop of a rapidly evolving landscape. They are bound to no agenda other than robustly executing their fiduciary duty and representing the best interests of the Company and all of its shareholders.
Kimmeridge urges shareholders to vote "FOR" all three of its highly-qualified nominees —
1 https://www.sec.gov/Archives/edgar/data/351817/000090266424001905/p24-0923sc13da.htm
Additional information
Additional information regarding Kimmeridge's definitive proxy statement can be found at www.Kimmeridge.com/sbow/. If you have any questions or require any assistance with voting your shares, please contact our proxy solicitor, Saratoga Proxy Consulting LLC, at (212) 257-1311, or (888) 368-0379 (toll free) or by email at [email protected].
About Kimmeridge
Founded in 2012 by
Media
Kekst CNC
[email protected]
Investors
Saratoga Proxy Consulting LLC
[email protected]
(212) 257-1311
Cautionary Statement Regarding Forward-Looking Statements
This press release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein in any state to any person. The information herein contains "forward-looking statements". Specific forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and include, without limitation, words such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "potential," "targets," "forecasts," "seeks," "could," "should" or the negative of such terms or other variations on such terms or comparable terminology. Similarly, statements that describe our objectives, plans or goals are forward-looking. Forward-looking statements are subject to various risks and uncertainties and assumptions. There can be no assurance that any idea or assumption herein is, or will be proven, correct or that any of the objectives, plans or goals stated herein will ultimately be undertaken or achieved. If one or more of such risks or uncertainties materialize, or if Kimmeridge underlying assumptions prove to be incorrect, the actual results may vary materially from outcomes indicated by these statements. Accordingly, forward-looking statements should not be regarded as a representation by Kimmeridge that the future plans, estimates or expectations contemplated will ever be achieved.
Important Information
Kimmeridge Energy Management Company, LLC, KEF Investments, LP, KEF Fund V Investments, LP,
View original content to download multimedia:https://www.prnewswire.com/news-releases/kimmeridge-issues-letter-calling-out-silverbows-misstatements-and-misrepresentation-of-kimmeridges-intent-302143612.html
SOURCE Kimmeridge
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TWO to repurchase $115M in senior notes after CrossCountry merger
- Allarity Therapeutics files SPAC registration for $100M IPO
- Impact BioMedical announces 1-for-12.62 reverse stock split ahead of merger
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share